Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy
Manuscript Number:
15-1028R2
Author(s):
Christine M. Baugh, Robert C. Cantu, Christine Chaisson, Nathan G. Fritts, Cicek Gercel-Taylor, Tsuneya Ikezu, James A. Joyce, Brett Martin, Sahil Shah, Robert Stern, Douglas D. Taylor, Yorghos Tripodis, Jing Zhang
Disclosures
Christine M. Baugh
Grants
Agency:
National Football League Players' Association
Dates:
November 1, 2015 - Present
Agency:
National Collegiate Athletic Association
Dates:
January 1, 2015 - December 30, 2015
Robert C. Cantu
Consulting Fees:
Robert C. Cantu is a paid consultant to the NFL Head Neck and Spine Committee, NOCSAE, Concussion Legacy Foundation, receives royalties from book publications, and compensation from expert legal opinion.
Patents/Royalties
Robert C. Cantu is a paid consultant to the NFL Head Neck and Spine Committee, NOCSAE, Concussion Legacy Foundation, receives royalties from book publications, and compensation from expert legal opinion.
Christine Chaisson
Nothing to Disclose
Nathan G. Fritts
Nothing to Disclose
Cicek Gercel-Taylor
Patents/Royalties
Patent as inventor on patent for isolation and identification of brain-derived exosomes
Tsuneya Ikezu
Nothing to Disclose
James A. Joyce
Equity:
I own 72,000 common shares and 157,143 stock purchase options in Aethlon Medical, Inc., a publicly traded company, which has majority ownership of Exosome Sciences, Inc.
Brett Martin
Nothing to Disclose
Sahil Shah
Nothing to Disclose
Robert Stern
Consulting Fees:
I am a paid advisory board member for: Avanir Pharmaceuticals, Amarantus Bioscience, and (upcoming) Biogen. I have also received consulting fees from attorneys representing collegiate athletes.
Patents/Royalties
I receive royalties for published neuropsychological tests from Psychological Assessment Resources, Inc.
Grants
Agency:
Avid Radiopharmaceuticals (additional study)
Dates:
2014-Present
Agency:
Eli Lilly
Dates:
2014-Present
Agency:
Amarantus Holdings
Dates:
2014-Present
Agency:
Eisai Inc
Dates:
2013-Present
Douglas D. Taylor
Patents/Royalties
Have a patent on the isolation and detection of brain-derived exsosmes.